CompletedNCT00179062
Risperidone compared with olanzapine for weight and health outcomes in mental health care
About this title
Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder
Read the official source — NCT00179062Medication studyAges 18–60United StatesBipolarity
Understand this study
Who was this study for?
Listed age limits: 18 years to 60 years.
- Listed locations
- NashvilleSee all locations and recruitment
Study information
Study start dateFebruary 2000
- Recruitment status
- Completed
- Enrollment listed in the registry
- 300
- Sponsor
- Vanderbilt University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT00179062
- Official title
Show the full official title
Effects of Risperidone and Olanzapine on Weight Gain, Physical Health, and Outcome in a Community Sample of Severity and Persistently Ill Patients
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Nashville
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Vanderbilt University, a university.
Did this study involve medication?
Yes. The study involved medication, including olanzapine versus risperidone.
Who was this study for?
Listed age limits: 18 years to 60 years.
